Skip Navigation

European Heart Journal 2004 25(12):1087; doi:10.1016/j.ehj.2003.12.034
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ueng, K.-C.
Right arrow Articles by Chen, S.-A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ueng, K.-C.
Right arrow Articles by Chen, S.-A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

Atrial remodelling in persistent atrial fibrillation: the potential role of aldosterone: Reply

Kwo-Chang Ueng*

Division of Cardiology, Institute of Medicine, Chung-Shan Medical University, Taichung. 110, Sec. 1, Chien-Kuo N. Road, Taichung, Taiwan

Shih-Ann Chen

School of Medicine, Taipei Veterans General Hospital-Taipei, National Yang-Ming University, Taiwan

* Tel.: +886-4-2253-2603; Fax: +886-4-2252-3626
E-mail address: ueng.kc@msa.hinet.net

The first 10% of the full text of this article appears below.

The letter by Dr. Korantzopoulos and co-workers made several good points that are of general interest to the issue of aldosterone in atrial fibrillation (AF). Without a doubt, our findings provide mechanistic support for clinical observations pointing to efficacy against AF-induced structural remodelling of angiotensin converting enzyme . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?